New Hope for Rapid-Acting Depression Treatment - National Institute of Mental Health (NIMH)
Resource type
Web Page
Title
New Hope for Rapid-Acting Depression Treatment - National Institute of Mental Health (NIMH)
Abstract
A new study, funded in part by the National Institute of Mental Health, showed that a new medication derived from ketamine is safe and acceptable for use in humans, setting the stage for clinical trials testing it for hard-to-treat mental disorders like severe depression.
Date
2024-10-24
Accessed
11/25/24, 4:32 AM
Language
en
Citation
New Hope for Rapid-Acting Depression Treatment - National Institute of Mental Health (NIMH). (2024, October 24). https://www.nimh.nih.gov/news/science-news/2024/new-hope-for-rapid-acting-depression-treatment
Link to this record